Niosomally encapsulated silver sulfadiazine gel for burn treatment

Journal of Microencapsulation

Volumn 32, Issue 2, 2015, Pages 137-142

  Dharashivkar, Sanket S ^a   Sahasrabuddhe, Sangeeta H ^a   Saoji, Ashok N ^a  

^a Affiliated to Mumbai University   (India)

Author keywords

Antimicrobial study; Burn model; Niosomal gel; Silver sulfadiazine

Indexed keywords

CARBOPOL 934; CHOLESTEROL; NIOSOME; NONIONIC SURFACTANT; SORBITAN STEARATE; SULFADIAZINE SILVER; ANTIINFECTIVE AGENT; GEL; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BURN; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DOSE INCREASE; FILM; GEL; IN VITRO STUDY; IN VIVO STUDY; INHIBITION ZONE; MOLECULAR SIZE; NONHUMAN; RAT; STAPHYLOCOCCUS AUREUS; TRANSMISSION ELECTRON MICROSCOPY; WOUND CONTRACTION; WOUND HEALING; ZETA POTENTIAL; ANIMAL; BURNS; CHEMISTRY; FEMALE; GROWTH, DEVELOPMENT AND AGING; MALE; WISTAR RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; BURNS; FEMALE; GELS; LIPOSOMES; MALE; RATS; RATS, WISTAR; SILVER SULFADIAZINE; STAPHYLOCOCCUS AUREUS;

EID: 84931092685     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2014.958202     Document Type: Article

References (27)

1. Andrew JL, Timothy BH, Heather RW, Peter MM, Peter BA, George TR. A new silver sulfadiazine water soluble gel. Burns, 1997; 23(5):387-91.
2. Bhanja S, Ellaiah P, Choudhury R, Murthy KVR, Panigrahi B, Padhy SK. Formulation, development and evaluation of mucoadhesive buccal patches of methotrexate. J Adv Pharm Res, 2010;1:17-25.
3. Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev, 2006;19(2):403-34.
4. Elbary AA, El-laithy HM, Tadros MI. Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium. Int J Pharm, 2008;357:189-98.
5. Fan M, Xu S, Xia S, Zhang X. Preparation of salidroside nano-liposomes by ethanol injection method and in vitro release study. Eur Food Res Technol, 2008;227:167-74.
6. Florence AT, Arunothayanun P, Bernard MS, Craig DM, Uchegbhu IF. The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether. Int J Pharm, 2000;201:7-14.
7. Foroutan SM, Ettehadi HA, Torabi HR. Formulation and in vitro evaluation of silver sulfadiazine spray. Iranian J Pharm Res, 2002;1: 47-9.
8. Ganesamoni S, Kate V, Sadasivan J. Epidemiology of hospitalized burn patients in a tertiary care hospital in South India. Burns, 2010; 3(6):422-29.
9. Guinedi AS, Mortada ND, Mansour S, Hathout RM. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm, 2005;306:71-82.
10. Hao Y, Zhao F, Li N, Yang Y, Li K. Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm, 2002;244:73-80.
11. Heredero FX, Hamann C, Obispo MJM, Rodriguez AC, Coca MS. Experimental burn models. Ann Burns Fire Disasters, 1996;9(2):1-6.
12. Ijeoma FU, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm, 1998;172:33-70.
13. Lichtenstein A, Margalit R. Liposome-encapsulated silver sulfadiazine for the topical treatment of infected burns: Thermodynamics of drug encapsulation and kinetics of drug release. J Inorg Biochem, 1995;60: 187-98.
14. MacMillan BG. The control of burn wound sepsis. Intensive Care Med, 1981;7(2):63-9.
15. Meyer TN, Silva AL. A standard burn model using rats. Acta Cir Bras, 1999;14(4):1-10.
16. Mi FL, Wu YB, Shyu SS, Chao AC, Lai JY, Su CC. Asymmetric chitosan membranes prepared by dry/wet phase separation: A new type of wound dressing for controlled antibacterial release. J Membr Sci, 2003; 212:237-54.
17. Ministry of Health & Family Welfare Government of India. 2010. The Indian pharmacopoeia commission, 6th edn. Ghaziabad, India: The Indian Pharmacopoeia Commission, pp. 49-54.
18. Momcilovic D. Topical agents used in the treatment of burns. Med Pregl, 2002;55(3-4):109-13.
19. Monafo WW, West MA. Current treatment recommendations for topical burn therapy. Drugs, 1990;40(3):364-73.
20. Mousa HA. Burn and scald injuries. East Mediterz Health J, 2005;11: 1099-109.
21. Nefise OS. 2007. Niosomes as nanocarrier systems. Netherlands: Springer Publisher, pp. 67-81.
22. Palmieri TL, Greenhalgh DG. Topical treatment of pediatric patients with burn: A pediatrical guide. Am J Clin Dermatol, 2002; 3(8):529-34.
23. RajaNaresh RA, Pillai GK, Udupa N, Chandrashekar G. Anti-inflammatory activity of niosome encapsulated diclofenac sodium in arthritic rats. Indian J Pharmacol, 1994;26:46-8.
24. Srivastava P, Durgaprasad S. Burn wound healing property of Cocos nucifera: An appraisal. Indian J Pharmacol, 2008;40(4):144-6.
25. The Ministry of Health, Labor and Welfare. 2006. Japanese Pharmacopoeia, 15th edn. Tokyo: The Ministry of Health, Labor and Welfare., pp. 1124-25.
26. Woo JS, Yong CS, Balakrishnan P, Shanmugam S, Lee WS, Lee WM, Kim JO, Oh DH, Kim DD, Kim JS, et al. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. Int J Pharm, 2009;377:1-8.
27. Yoshioka T, Stermberg B, Florence AT. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and sorbitan triester (Span 85). Int J Pharm, 1994;105:1-6.